G
Galectin Therapeutics D
D
GALT
2.17000
USD
0.02
(0.93%)
مغلق
حجم التداول
3,108
الربح لكل سهم
-1
العائد الربحي
-
P/E
-3
حجم السوق
137,342,739
الأخبار المقالات
العنوان: Galectin Therapeutics
القطاع: Healthcare
الصناعة: Biotechnology
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.